| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |